{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T06:22:27Z","timestamp":1791699747742,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008614","name":"Wesley Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010847","name":"Coeliac Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008613","name":"Wesley Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1053\/j.gastro.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:04:13Z","timestamp":1774533853000},"page":"285-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Randomized Double-Blind, Placebo-Controlled Dose\u2013Response Study to Assess the Gluten Threshold Dose in Celiac Disease"],"prefix":"10.1053","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6042-5102","authenticated-orcid":false,"given":"A. James M.","family":"Daveson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Vitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"Colgrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda Y.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Tye-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.03.011_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.03.011_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.03.011_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.03.011_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrgastro.2015.156","article-title":"Practical insights into gluten-free diets","volume":"12","author":"See","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.03.011_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease","volume":"85","author":"Catassi","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2026.03.011_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ajcn\/nqx049","article-title":"Determination of gluten consumption in celiac disease patients on a gluten-free diet","volume":"107","author":"Syage","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2026.03.011_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13107","article-title":"Evolution in coeliac disease diagnosis and management","volume":"8","author":"Tye-Din","year":"2024","journal-title":"JGH Open"},{"key":"10.1053\/j.gastro.2026.03.011_bib11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.13369","article-title":"Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease","volume":"199","author":"Goel","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2026.03.011_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw7756","article-title":"Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease","volume":"5","author":"Goel","year":"2019","journal-title":"Sci Adv"},{"key":"10.1053\/j.gastro.2026.03.011_bib13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/apt.15477","article-title":"Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential biomarker for coeliac disease","volume":"50","author":"Tye-Din","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.03.011_bib14","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2025.05.022","article-title":"Blood-based T cell diagnosis of celiac disease","volume":"169","author":"Moscatelli","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.03.011_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fct.2013.10.032","article-title":"Establishment of reference doses for residues of allergenic foods: report of the VITAL Expert Panel","volume":"63","author":"Taylor","year":"2014","journal-title":"Food Chem Toxicol"},{"key":"10.1053\/j.gastro.2026.03.011_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaci.2012.10.034","article-title":"Threshold dose distributions for 5 major allergenic foods in children","volume":"131","author":"Blom","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.gastro.2026.03.011_bib17","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3389\/fimmu.2018.02057","article-title":"Eliciting dose and safety outcomes from a large dataset of standardized multiple food challenges","volume":"9","author":"Purington","year":"2018","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2026.03.011_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/apt.15551","article-title":"Marked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease","volume":"51","author":"Daveson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2026.03.011_bib19","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2019.12.016","article-title":"Most patients with celiac disease on gluten-free diets consume measurable amounts of gluten","volume":"158","author":"Silvester","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.03.011_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076163","article-title":"Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease","volume":"8","author":"Taavela","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2026.03.011_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ygh2.380","article-title":"Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten-free diet","volume":"2","author":"Daveson","year":"2020","journal-title":"GastroHep"},{"key":"10.1053\/j.gastro.2026.03.011_bib22","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.14309\/ajg.0000000000001139","article-title":"Persistent villous atrophy in de novo adult patients with celiac disease and strict control of gluten-free diet adherence: a multicenter prospective study (CADER Study)","volume":"116","author":"Fern\u00e1ndez-Ba\u00f1ares","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2026.03.011_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.03.011_bib25","first-page":"44","article-title":"Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease:","volume":"10","author":"Daveson","year":"2024","journal-title":"a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Gastro Hep"},{"key":"10.1053\/j.gastro.2026.03.011_bib26","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/gutjnl-2012-302196","article-title":"Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease","volume":"62","author":"Leffler","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2026.03.011_bib27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/nu14091771","article-title":"Dose-escalating (50-500 mg) gluten administration leads to detectable gluten-immunogenic-peptides in urine of patients with coeliac disease which is unrelated to symptoms, a placebo controlled trial","volume":"14","author":"Burger","year":"2022","journal-title":"Nutrients"},{"key":"10.1053\/j.gastro.2026.03.011_bib28","doi-asserted-by":"crossref","first-page":"12390","DOI":"10.1073\/pnas.2135229100","article-title":"The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses","volume":"100","author":"Vader","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2026.03.011_bib29","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cgh.2024.08.005","article-title":"Biopsy proteome score performs well as an effect measure in a gluten challenge trial of celiac disease","volume":"23","author":"Johansen","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.03.011_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcmgh.2020.07.010","article-title":"Genome-wide transcriptomic analysis of intestinal mucosa in celiac disease patients on a gluten-free diet and postgluten challenge","volume":"11","author":"Dotsenko","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526002647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526002647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:29:14Z","timestamp":1785972554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526002647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0016508526002647"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.03.011","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Double-Blind, Placebo-Controlled Dose\u2013Response Study to Assess the Gluten Threshold Dose in Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}]}}